| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |